<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="impaired its attachment and internalization. Nonetheless, inhibition of ASMase by" exact="desipramine" post="did not affect IAV infection. Similarly, virus replication was"/>
 <result pre="glutamax (100X), 1% penicillin-streptomycin (10,000 units penicillin and 10,000 units" exact="streptomycin" post="per ml) and 0.08% gentamicin (50 mg/ml). VIM was"/>
 <result pre="assay as described below. Reagent Preparation A 10 mM of" exact="desipramine" post="(Sigma, D3900) stock, an inhibitor of ASMase (Hurwitz et"/>
 <result pre="a functional inhibitor of ASMase. Dose and time-dependent cytotoxicity of" exact="desipramine" post="on A549 cells were first studied using MTT assay."/>
 <result pre="up to 48 h (Figure 4B). We further verified that" exact="desipramine" post="(25 μM) treatment significantly reduces ASMase activity in A549"/>
 <result pre="4 ASMase is dispensable for IAV infection (A,B) Cytotoxicity of" exact="desipramine" post="(Des) in A549 cells was assessed using the MTT"/>
 <result pre="using the MTT assay. A549 cells were treated with increasing" exact="desipramine" post="concentrations for 24 h (A) or with desipramine at"/>
 <result pre="with increasing desipramine concentrations for 24 h (A) or with" exact="desipramine" post="at 12.5 μM or 25 μM for the indicated"/>
 <result pre="μM for the indicated durations (B). (C) The effect of" exact="desipramine" post="on ASMase activity in A549 cells was determined. A549"/>
 <result pre="to the vehicle-treated cells. A549 cells were either treated with" exact="desipramine" post="for 1 h or left untreated prior to inoculation"/>
 <result pre="ASMase inhibition on IAV propagation. A549 cells were treated with" exact="desipramine" post="for 1 h before inoculation with 1 MOI of"/>
 <result pre="was maintained in the culture media during infection. Treatment with" exact="desipramine" post="at 12.5 and 25 μM did not affect IAV"/>
 <result pre="et al., 2012; Huang et al., 2018), ASMase inhibition using" exact="desipramine" post="did not affect IAV infection. Furthermore, IAV was able"/>
 <result pre="belongs to the group of lysosomotropic weak bases, which includes" exact="amantadine" post="and chloroquine, both known to inhibit IAV (Wang et"/>
 <result pre="al., 2010). A common mechanism underlying the inhibitory effect of" exact="amantadine" post="and chloroquine against IAV is through inhibiting endosomal activation"/>
 <result pre="A common mechanism underlying the inhibitory effect of amantadine and" exact="chloroquine" post="against IAV is through inhibiting endosomal activation and low-pH"/>
 <result pre="(Steinhauer et al., 1991; Di Trani et al., 2007). Besides," exact="amantadine" post="blocks the viral M2 channel and subsequently inhibits the"/>
 <result pre="virus life cycle (Wang et al., 1993). In this study," exact="desipramine" post="had no inhibitory effect against IAV despite being a"/>
 <result pre="is much less potent in neutralizing endosomal vesicles compared to" exact="chloroquine" post="albeit having a higher inhibitory effect against ASMase (Kornhuber"/>
 <result pre="et al., 2011). Therefore, the lack of inhibitory effect by" exact="desipramine" post="against IAV might be both due to its failure"/>
 <result pre="Different pH requirements are associated with divergent inhibitory effects of" exact="chloroquine" post="on human and avian influenza A viruses.Virol. J.4:39. 10.1186/1743-422X-4-3917477867"/>
 <result pre="(MDCK) cells.J. Virol. Methods1117–120. 10.1016/0166-0934(80)90020-87228969 HurwitzR.FerlinzK.SandhoffK. (2009). The tricyclic antidepressant" exact="desipramine" post="causes proteolytic degradation of lysosomal sphingomyelinase in human fibroblasts.Biol."/>
 <result pre="activity of influenza A virus M2 protein: characterization of the" exact="amantadine" post="block.J. Virol.675585–5594. 10.1128/jvi.67.9.5585-5594.19937688826 WengL.HirataY.AraiM.KoharaM.WakitaT.WatashiK.et al. (2010). Sphingomyelin activates hepatitis"/>
</results>
